CDC Narrows RSV Vaccine Guidelines Due to Safety Concerns
The U.S. Centers for Disease Control and Prevention (CDC) has recently narrowed its original recommendations for the respiratory syncytial virus (RSV) vaccine, citing concerns over the risk of a side effect that can lead to paralysis or death. The recommendations originally stated adults over the age of 60 should receive the vaccine, but updates in […]
Vaccines, Doses & Shots. Confused?
In a phone conversation with Robert F. Kennedy, Jr. regarding childhood vaccinations last month, Donald Trump said: When you feed a baby, Bobby, a vaccination that is, like, 38 different vaccines and it looks like it’s been for a horse. Not a, you know, 10-pound or 20-pound baby. And then you see the baby all […]
Guillain-Barré Syndrome ‘More Common Than Expected’ in Early RSV Vaccine Trial
Reports of the nervous system disorder Guillain-Barré syndrome (GBS) were “more common than expected” in the older adult population who received the new vaccine for respiratory syncytial virus (RSV). The data, reported by the U.S. Centers for Disease Control and Prevention (CDC), matched trial data reported earlier this year.1 GBS is a “polio-like” inflammatory autoimmune […]
U.S. Stockpiles Two Bird Flu Vaccines
U.S. government health officials announced earlier this month that two bird flu vaccines are being stockpiled and will be available for shipment within weeks. They said that the bird flu stockpiling is part of their emergency preparations in the event the H5N1 virus, which now primarily infects wild birds, chickens and sometimes cows and other […]
Bird Flu Outbreaks & the WHO/IHR Pandemic Treaty Push
Even as U.S. health agencies and the United Nations World Health Organization (WHO) are being heavily criticized for their botched response to the COVID-19 pandemic,1 2 3 WHO officials are ramping up pressure on all nations to sign a WHO pandemic treaty and amendments to the WHO’s International Health Regulations (IHR), which will give them […]
RSV Vaccines for Senior Adults Linked to Guillain-Barré Syndrome
On Feb. 29, 2024, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) presented a preliminary analysis that showed that 23 adults over the age of 65 who received a respiratory syncytial virus (RSV) vaccine developed Guillain-Barré syndrome (GBS).1 When a person develops GBS, including after an infection or […]